You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Solid Tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors Trial (INCA33890)

Not yet recruiting
  • Solid Tumors
  • +2 more
  • (no location specified)
Apr 26, 2023

Advanced Solid Tumors Trial (QL1706H)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Sep 18, 2023

Refractory Solid Tumors, Relapsed Solid Tumors Trial in Beijing (KSX01-TCRT cell therapy)

Recruiting
  • Refractory Solid Tumors
  • Relapsed Solid Tumors
  • KSX01-TCRT cell therapy
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 21, 2023

Solid Tumors Trial (GS-9911, Zimberelimab)

Not yet recruiting
  • Solid Tumors
  • (no location specified)
Oct 9, 2023

Advanced Solid Tumors Trial (AMG 355, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Nov 9, 2023

NHWD-870 in Advanced Solid Tumors or Lymphomas Carrying NUT

Recruiting
  • Advanced Solid Tumors or Lymphomas
  • Changsha, Hunan, China
    Hunan Provincal Tumor Hospital
Oct 5, 2023

Advanced Solid Cancer Trial (ORB-011)

Not yet recruiting
  • Advanced Solid Cancer
  • (no location specified)
Jul 14, 2023

Advanced Solid Tumors With Neuroendocrine Differentiation Trial (surufatinib?serplulimab)

Not yet recruiting
  • Advanced Solid Tumors With Neuroendocrine Differentiation
  • (no location specified)
Nov 27, 2023

Solid Tumors Trial (IBR854 Cell Injection)

Not yet recruiting
  • Solid Tumors
  • IBR854 Cell Injection
  • (no location specified)
Aug 14, 2023

Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors Trial (RO7566802, Atezolizumab)

Not yet recruiting
  • Locally Advanced Solid Tumors
  • +2 more
  • (no location specified)
Sep 4, 2023

Advanced Solid Tumors Trial (SHR-1826)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Oct 16, 2023

Metastatic Solid Tumors, Advanced Solid Tumors Trial (MK-0472, Pembrolizumab)

Not yet recruiting
  • Metastatic Solid Tumors
  • Advanced Solid Tumors
  • (no location specified)
May 2, 2023

GT316,Solid Tumors,Adult Trial in Zhengzhou (GT316)

Recruiting
  • GT316,Solid Tumors,Adult
  • GT316
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Oct 16, 2023

Advanced Solid Tumors Trial (SKB410 for injection)

Not yet recruiting
  • Advanced Solid Tumors
  • SKB410 for injection
  • (no location specified)
Jun 13, 2023

Advanced Malignant Solid Tumors Trial (Neoantigen mRNA Personalised Cancer vaccine)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Neoantigen mRNA Personalised Cancer vaccine
  • (no location specified)
Jul 16, 2023

Advanced Solid Tumors, B-cell Non-Hodgkin Lymphomas Trial (ATG-031)

Not yet recruiting
  • Advanced Solid Tumors
  • B-cell Non-Hodgkin Lymphomas
  • (no location specified)
Aug 31, 2023

HER2-expressing Advanced Solid Tumors Trial (SHR-A1811 combined with Pyrotinib., SHR-A1811 combined with other antitumor

Not yet recruiting
  • HER2-expressing Advanced Solid Tumors
  • SHR-A1811 combined with Pyrotinib.
  • SHR-A1811 combined with other antitumor therapies
  • (no location specified)
Aug 28, 2023

Precision Medicine Treatment for Refractory Solid Tumors

Recruiting
  • Refractory Solid Tumors
  • Next Generation Sequencing
    • Tianjin, Tianjin, China
      Tianjin Medical University Second Hospital
    Sep 2, 2023

    Advanced Solid Tumors Trial in Hangzhou (ZGGS15)

    Not yet recruiting
    • Advanced Solid Tumors
    • ZGGS15
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    May 17, 2023

    Tumor Vaccines for Solid Tumors

    Recruiting
    • Glioma
    • Solid Tumor
    • tumor vaccine
    • +3 more
    • Shanghai, Shanghai, China
      Huashan Hospital, Fudan University
    Oct 22, 2023

    Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)

    Recruiting
    • Refractory Solid Tumors
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 22, 2023

    Solid Tumors, Adult Trial in Xuzhou (TIL injection)

    Recruiting
    • Solid Tumors, Adult
    • TIL injection
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital Of Xuzhou Medical University
    Oct 12, 2023

    NSCLC, Breast Cancer, HNSCC Trial in Chang chun (YL202 should be intravenously infused)

    Not yet recruiting
    • NSCLC
    • +3 more
    • YL202 should be intravenously infused
    • Chang chun, Jilin, China
      Jilin Provincial Cancer Hospital
    Oct 25, 2023

    Advanced Solid Tumors Trial (INCB099280, axitinib)

    Not yet recruiting
    • Advanced Solid Tumors
    • (no location specified)
    Jul 18, 2023

    Mesothelin-positive Advanced Malignant Solid Tumors Trial (Anti-mesothelin CAR-T cells)

    Not yet recruiting
    • Mesothelin-positive Advanced Malignant Solid Tumors
    • Anti-mesothelin CAR-T cells
    • (no location specified)
    Mar 13, 2023